← Eichor
Condition: Colorectal Cancer Crc Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Colorectal Cancer Crc

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Pa
Phase 3 · 60 location(s) · ECOG-ACRIN Cancer Research Group · NCT05863195Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Phase 1 · 40 location(s) · TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) · NCT06625775A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic
Phase 1 · 26 location(s) · R-Pharm · NCT07543744Tracking Mutations in Cell Free Tumour DNA to Predict Relapse in Early Colorectal Cancer
Phase N/A · 71 location(s) · Royal Marsden NHS Foundation Trust · NCT04050345Liver Transplantation for Non-Resectable Colorectal Liver Metastasis
NA · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT05185245Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Phase 1 · 29 location(s) · Novartis Pharmaceuticals · NCT06562192Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
Phase N/A · 1 location(s) · University of Missouri-Columbia · NCT02838836A Prospective Cohort Study on Colorectal Cancer Screening in Community Population
Phase N/A · 1 location(s) · Singlera Genomics Inc. · NCT05485077FOLICOLOR TRIAL: Following Therapy Response Through Liquid Biopsy in Metatstatic Colorectal Cancer Patients
Phase 3 · 9 location(s) · University Hospital, Antwerp · NCT07558083Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Phase 1/Phase 2 · 27 location(s) · Institut de Recherches Internationales Servier · NCT05786924AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer
Phase 3 · 2 location(s) · Akeso · NCT06951503Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT07448142Superior HypogastrIc plExus bLock During Laparoscopic Colorectal Cancer Surgery
NA · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT07579780FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-S
Phase 2 · 13 location(s) · Oncolytics Biotech · NCT07446322PSYLIVED: the Psychological Impacts of Living With an Inherited Colorectal Cancer Predisposition Syndrome
Phase N/A · 1 location(s) · London North West Healthcare NHS Trust · NCT06447961Chlorhexidine Gluconate Versus Saline for Flushing the Surgical Area During Colorectal Cancer Surgery
NA · 1 location(s) · Nanchong Central Hospital · NCT06869096NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Ca
Phase 3 · 1 location(s) · Shanghai Zhongshan Hospital · NCT07309289IX001 TCR-T In the Treatment of Advanced Pancreatic Cancer and Colorectal Cancer Induced by KRAS Mutations
Phase 1 · 1 location(s) · Shanghai Pudong Hospital · NCT06487377Comparative Study on the Short- and Long-term Efficacy of Q-ISR, Traditional Sub-ISR, and t-ISR
Phase 2 · 1 location(s) · Fudan University · NCT07371273Assessment of Direct Biomarkers of Aspirin Action to Develop a Precision Chemoprevention Therapy of Colorectal Cancer
Phase 2 · 1 location(s) · Instituto de Investigación Sanitaria Aragón · NCT03957902alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Recep
Phase 1 · 4 location(s) · Celyad Oncology SA · NCT03692429Effects of UNICLA-A2 Dairy Products on Patients at High-risk of Colorectal Cancer Development
NA · 1 location(s) · Instituto de Investigación Sanitaria Aragón · NCT04824053The Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune Checkpoint Inhibitorrs in First-line
Phase 2 · 1 location(s) · Zhejiang University · NCT07257653Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
Phase 1 · 5 location(s) · National Cancer Institute (NCI) · NCT05630794Effectiveness of a Self-health Assessment Mobile Application in Young-to-midlife Adults in Hong Kong
NA · 1 location(s) · The University of Hong Kong · NCT07720245Functional and Respiratory Determinants of Long-Term Colorectal Cancer Outcomes
Phase N/A · 1 location(s) · Inonu University · NCT07523919Pre-emptive Endoscopic Vacuum Therapy Reduces the Incidence of Anastomotic Leakage After Colorectal Cancer Surgery
NA · 1 location(s) · Nanchong Central Hospital · NCT07208786Digestive Biobank for Exploring Microbiota-host Interactions
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05704413Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastati
Phase 1 · 22 location(s) · National Cancer Institute (NCI) · NCT05803382Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)
Phase 2 · 1 location(s) · Ciusss de L'Est de l'Île de Montréal · NCT05913674
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.